Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Subscribe to Pharma in Focus

Sign Up Now

Pharma in Focus is considered essential daily reading in the Australian and NZ pharma industry.

In production for 14 years, it is emailed twice daily to more than 11,000 pharma industry professionals throughout Australia and NZ.

For just $454.50 a year (plus GST) Pharma in Focus puts you ahead of the game by delivering:

  • Key Aussie & NZ pharma news every working day
  • Daily in-depth features covering all aspects of pharma from drug approvals to employment issues
  • Full coverage and analysis of PBAC, PBS and TGA decisions
  • Ten survey-based white papers per year (total value $1500)

New to Pharma in Focus? Sign up below for your FREE two week trial.

Time to subscribe? Sign up below for your 12 month subscription.

Need multiple licenses? We have great corporate rates. Contact our friendly subscription managers on 02 9939 1881 or for our latest prices.

3 Simple Steps

1 Fill in your details below and submit

2 Make your subscription choice

3 Make your payment choice (Credit Card, Direct Deposit or Cheque)

No 'safe' level of HCP sponsorship
Australian pharma has made considerable concessions in recent years to prove it has nothing to hide in doctor education payments but is it worth the pain if it fails to silence the critics?
Approvals Action
New AbbVie, Sanofi therapies kick off 2018
AbbVie and Sanofi have both seen new products registered on the ARTG over the past month while generic companies have made moves on older therapies.
Special Report
PBAC March agenda in full
The PBAC will consider 63 submissions at its March meeting, although the number of major submissions has been dialled back when compared to its bumper meet-up of last month.